Skip to content

R&D at other companies

Biogen logo
BiogenBIIB
$539M+24.2%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$100.87M-7.4%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$57.09M+21.8%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$75.37M+19.6%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$126.64M+13.6%
Arrowhead Research logo
Arrowhead ResearchARWR
$173.25M+30.2%

Segments

By product

See full
Apitegromab$20.26M
RD Expense Srk439$1.76M
Early Research$1.21M-16.8%
RD Expense Srk181$36K

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%
Enterprise value$5.45B+82.6%
P/S170.9×

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's R&D?
Scholar Rock (SRRK) reported R&D of $51.81M in Q1 2026.
How has Scholar Rock's R&D changed year-over-year?
Scholar Rock's R&D increased by 6.4% year-over-year, from $48.68M to $51.81M.
What is the long-term trend for Scholar Rock's R&D?
Over 4 years (2021 to 2025), Scholar Rock's R&D has grown at a 17.7% compound annual growth rate (CAGR), from $108.47M to $208.44M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.